Spectrum Pharmaceuticals Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Employees
-
86
- Latest Deal Type
-
M&A
- Financing Rounds
-
14
- Investments
-
8
Spectrum Pharmaceuticals General Information
Description
Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations. It has one segment that is focused exclusively on developing and marketing oncology and hematology drug products.
Contact Information
Website
www.sppirx.comCorporate Office
- Pilot House - Lewis Wharf, 2 Atlantic Avenue
- 6th Floor
- Boston, MA 02110
- United States
Corporate Office
- Pilot House - Lewis Wharf, 2 Atlantic Avenue
- 6th Floor
- Boston, MA 02110
- United States
Spectrum Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Spectrum Pharmaceuticals Comparisons
Industry
Financing
Details
Spectrum Pharmaceuticals Competitors (43)
One of Spectrum Pharmaceuticals’s 43 competitors is Coherus Oncology, a Formerly VC-backed company based in Redwood City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Coherus Oncology | Formerly VC-backed | Redwood City, CA | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Nanoviricides | Corporation | Shelton, CT | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Moderna | Formerly VC-backed | Cambridge, MA |
Spectrum Pharmaceuticals Patents
Spectrum Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230277628-A1 | Methods for promoting anti-tumor immune response in a subject in need thereof using encapsulated interleukin 12 | Inactive | 04-Mar-2022 | ||
| WO-2023015149-A1 | Treatment of non-small cell lung cancer with poziotinib | Inactive | 02-Aug-2021 | ||
| WO-2022147150-A1 | Treatment of malignant solid tumors | Inactive | 29-Dec-2020 | ||
| WO-2022087371-A1 | Novel bicyclic compounds | Inactive | 22-Oct-2020 | ||
| WO-2022087375-A1 | Novel heterocyclic compounds | Inactive | 22-Oct-2020 | A61K45/06 |
Spectrum Pharmaceuticals Signals
Spectrum Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Spectrum Pharmaceuticals Investments & Acquisitions (8)
Spectrum Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with ImmunGene (Focused Interferon Therapeutics) for . The deal was made on 09-May-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ImmunGene (Focused Interferon Therapeutics) | 09-May-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Valerio Therapeutics | 13-Nov-2014 | PIPE | Biotechnology | ||
| Talon Therapeutics | 18-Jun-2013 | Merger/Acquisition | Pharmaceuticals | ||
| Allos Therapeutics | 05-Sep-2012 | Merger/Acquisition | Drug Discovery | ||
| RIT Oncology | 15-Mar-2009 | Merger/Acquisition | Drug Discovery |
Spectrum Pharmaceuticals FAQs
-
When was Spectrum Pharmaceuticals founded?
Spectrum Pharmaceuticals was founded in 1987.
-
Where is Spectrum Pharmaceuticals headquartered?
Spectrum Pharmaceuticals is headquartered in Boston, MA.
-
What is the size of Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals has 86 total employees.
-
What industry is Spectrum Pharmaceuticals in?
Spectrum Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Spectrum Pharmaceuticals a private or public company?
Spectrum Pharmaceuticals is a Private company.
-
What is the current valuation of Spectrum Pharmaceuticals?
The current valuation of Spectrum Pharmaceuticals is .
-
What is Spectrum Pharmaceuticals’s current revenue?
The current revenue for Spectrum Pharmaceuticals is .
-
How much funding has Spectrum Pharmaceuticals raised over time?
Spectrum Pharmaceuticals has raised $298M.
-
Who are Spectrum Pharmaceuticals’s investors?
Federated Kaufmann Fund, LRG Capital, and UMS Partners have invested in Spectrum Pharmaceuticals.
-
Who are Spectrum Pharmaceuticals’s competitors?
Coherus Oncology, Alnylam Pharmaceuticals, Nanoviricides, Gilead, and Moderna are some of the 43 competitors of Spectrum Pharmaceuticals.
-
When was Spectrum Pharmaceuticals acquired?
Spectrum Pharmaceuticals was acquired on 31-Jul-2023.
-
Who acquired Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals was acquired by Assertio Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process